Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Standardization of ischemia-modified albumin testing: adjustment for serum albumin.

Literature DB >> 17311519

Standardization of ischemia-modified albumin testing: adjustment for serum albumin.

Giuseppe Lippi, Martina Montagnana, Gian Luca Salvagno, Gian Cesare Guidi.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Serum Albumin

Year: 2007 PMID： 17311519 DOI： 10.1515/CCLM.2007.039

Source DB: PubMed Journal: Clin Chem Lab Med ISSN： 1434-6621 Impact factor: 3.694

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

1. Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis.

Authors: Husniye Baser; Ummugulsum Can; Salih Baser; Fatma Humeyra Yerlikaya; Uysaler Aslan; Bahauddin Taha Hidayetoglu
Journal: Endocrine Date: 2014-08-23 Impact factor: 3.633

2. Evaluation of the Relationship Between Ischemia-Modified Albumin Levels and Thyroid Hormone Levels.

Authors: Mufide Oncel; Aysel Kıyıcı; Serife Onen
Journal: J Clin Lab Anal Date: 2014-06-21 Impact factor: 2.352

3. Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?

Authors: Aysel Kiyici; Idris Mehmetoğlu; Hatice Karaoğlan; Hüseyin Atalay; Yalçin Solak; Süleyman Türk
Journal: J Clin Lab Anal Date: 2010 Impact factor: 2.352

4. Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction.

Authors: James Chek; Jaroslav Dusek; Josef Stasek; Jan Vojacek; Josef Bis; Martina Ulrychova; Milos Tichy; Tomas Tomko; Josef Bukac
Journal: Heart Vessels Date: 2011-01-26 Impact factor: 2.037

5. Ischemia-modified albumin levels in overt and subclinical hypothyroidism.

Authors: S V Reddy; M M Suchitra; V Pradeep; S Alok; V Suresh; A R Bitla; P V L N Srinivasa Rao
Journal: J Endocrinol Invest Date: 2015-04-11 Impact factor: 4.256

6. Apelin, Omentin-1, and Vaspin in patients with essential hypertension: association of adipokines with trace elements, inflammatory cytokines, and oxidative damage markers.

Authors: Fatma Behice Serinkan Cinemre; Hakan Cinemre; Nurten Bahtiyar; Behlül Kahyaoğlu; Mustafa Tarık Ağaç; Harika Shundo; Leyla Sevinç; Birsen Aydemir
Journal: Ir J Med Sci Date: 2020-06-24 Impact factor: 1.568

Standardization of ischemia-modified albumin testing: adjustment for serum albumin.

1. Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis.

2. Evaluation of the Relationship Between Ischemia-Modified Albumin Levels and Thyroid Hormone Levels.

3. Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?

4. Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction.

5. Ischemia-modified albumin levels in overt and subclinical hypothyroidism.

6. Apelin, Omentin-1, and Vaspin in patients with essential hypertension: association of adipokines with trace elements, inflammatory cytokines, and oxidative damage markers.

7. Ischemia-modified albumin as a biochemical marker in children with neuroblastoma and soft tissue sarcomas.

8. Effect of hemodialysis on traditional and innovative cardiac markers.

9. Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease.

10. Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure.